Therefore, from the perspective of cellular senescence, reduced expression of BMAL1 in breast cancer may weaken antisenescence defense mechanisms, making cancer cells more prone to accumulating DNA damage and promoting cancer progression. This evidence concerns the gene BMAL1 and breast carcinoma.